These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25497974)

  • 1. Thrombomodulin inhibits the activation of eosinophils and mast cells.
    Roeen Z; Toda M; D'Alessandro-Gabazza CN; Onishi M; Kobayashi T; Yasuma T; Urawa M; Taguchi O; Gabazza EC
    Cell Immunol; 2015 Jan; 293(1):34-40. PubMed ID: 25497974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
    Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
    J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic compound, 4-acetyl-3-methyl-6-(3,4,5-trimethoxyphenyl)pyrano[3,4-c]pyran-1,8-dione, ameliorates ovalbumin-induced asthma.
    Chung HS; Kim Y; Oh SJ; Kim H; Choi SI; Zhang Y; Jeong JH; Bae H
    Bioorg Med Chem; 2013 Nov; 21(21):6359-65. PubMed ID: 24054491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiallergic and antiasthmatic effects of a novel enhydrazinone ester (CEE-1): inhibition of activation of both mast cells and eosinophils.
    Ezeamuzie CI; El-Hashim AZ; Renno WM; Edafiogho IO
    J Pharmacol Exp Ther; 2014 Aug; 350(2):444-54. PubMed ID: 24917545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing glycosphingolipid biosynthesis in airway cells partially ameliorates disease manifestations in a mouse model of asthma.
    Karman J; Tedstone JL; Gumlaw NK; Zhu Y; Yew N; Siegel C; Guo S; Siwkowski A; Ruzek M; Jiang C; Cheng SH
    Int Immunol; 2010 Jul; 22(7):593-603. PubMed ID: 20497953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
    Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F
    Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
    Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
    Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
    Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells.
    Takagi T; Taguchi O; Toda M; Ruiz DB; Bernabe PG; D'Alessandro-Gabazza CN; Miyake Y; Kobayashi T; Aoki S; Chiba F; Yano Y; Conway EM; Munesue S; Yamamoto Y; Yamamoto H; Suzuki K; Takei Y; Morser J; Gabazza EC
    Am J Respir Crit Care Med; 2011 Jan; 183(1):31-42. PubMed ID: 20709825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of airway inflammation in bronchial asthma.
    Nakagome K; Nagata M
    Auris Nasus Larynx; 2011 Oct; 38(5):555-63. PubMed ID: 21334836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
    Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
    Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.
    Gauvreau GM; Watson RM; O'Byrne PM
    Am J Respir Crit Care Med; 1999 Aug; 160(2):640-7. PubMed ID: 10430741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation.
    Lamkhioued B; Renzi PM; Abi-Younes S; Garcia-Zepada EA; Allakhverdi Z; Ghaffar O; Rothenberg MD; Luster AD; Hamid Q
    J Immunol; 1997 Nov; 159(9):4593-601. PubMed ID: 9379061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin 1-derived peptide Ac2-26 inhibits eosinophil recruitment in vivo via decreasing prostaglandin D₂.
    Wang LM; Li WH; Xu YC; Wei Q; Zhao H; Jiang XF
    Int Arch Allergy Immunol; 2011; 154(2):137-48. PubMed ID: 20733322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action.
    Das AM; Flower RJ; Perretti M
    J Immunol; 1997 Aug; 159(3):1466-73. PubMed ID: 9233645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release.
    Erpenbeck VJ; Fischer I; Wiese K; Schaumann F; Schmiedl A; Nassenstein C; Krug N; Hohlfeld JM
    Int Arch Allergy Immunol; 2009; 149(4):333-42. PubMed ID: 19295237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
    Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
    Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx.
    Vieira-de-Abreu A; Amendoeira FC; Gomes GS; Zanon C; Chedier LM; Figueiredo MR; Kaplan MA; Frutuoso VS; Castro-Faria-Neto HC; Weller PF; Bandeira-Melo C; Bozza PT
    Int Immunopharmacol; 2005 Dec; 5(13-14):1966-74. PubMed ID: 16275631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.